Propuesta para la inclusión de la profilaxis pre exposición (prep) en los protocolos de control y seguimiento desarrollados en pacientes de (VIH) positivo de la IPS vivir bien de Cartagena de Indias.

Abstract

This research proposes a prevention strategy for HIV infection since it is one of the main critical pathologies of public health at the global, national and local levels. Therefore, its main objective is to identify the protocols applied by the health professionals of the IPS Vivir Bien in reference to HIV positive patients and the use of PrEP as an alternative to mitigate HIV infection. The research is of the exploratory-descriptive type, and of a mixed nature, where quantitative results were obtained and analyzed, as well as the consulted literature that allowed obtaining qualitative results of the research. The instrument used (questionnaire of closed questions) was applied to a group of health professionals, belonging to the IPS Vivir Bien of the city of Cartagena, which is presented as a research niche, in which all the survey activity is developed, information gathering, application of the instrument (personalized survey of health professionals), which consisted of 17 questions, on the liker scale and which allowed identifying the different perceptions of professionals regarding knowledge of Pre-exposure Prophylaxis (PrEP ), the control and follow-up protocols for HIV patients, and the veracity and effectiveness of the proposed drug (PrEP). Since it is a treatment that prevents HIV infection, and is aimed at people with previous exposure to the virus and high-risk populations.

Key words: Pre-exposure prophylaxis (PrEP), HIV seropositive, Tenofovir disoproxil fumarate (TDF), Emtricitabine (FTC).